Skip to main content
Top
Published in: BMC Infectious Diseases 1/2006

Open Access 01-12-2006 | Research article

Secular trends of antimicrobial resistance of blood isolates in a newly founded Greek hospital

Authors: Matthew E Falagas, Sofia K Kasiakou, Dimitra Nikita, Panayiota Morfou, George Georgoulias, Petros I Rafailidis

Published in: BMC Infectious Diseases | Issue 1/2006

Login to get access

Abstract

Background

Antimicrobial resistance is one of the most challenging issues in modern medicine.

Methods

We evaluated the secular trends of the relative frequency of blood isolates and of the pattern of their in vitro antimicrobial susceptibility in our hospital during the last four and a half years.

Results

Overall, the data regarding the relative frequency of blood isolates in our newly founded hospital do not differ significantly from those of hospitals that are functioning for a much longer period of time. A noteworthy emerging problem is the increasing antimicrobial resistance of Gram-negative bacteria, mainly Acinetobacter baumannii and Klebsiella pneumoniae to various classes of antibiotics. Acinetobacter baumannii isolates showed an increase of resistance to amikacin (p = 0.019), ciprofloxacin (p = 0.001), imipenem (p < 0.001), and piperacillin/tazobactam (p = 0.01) between the first and second period of the study.

Conclusion

An alarming increase of the antimicrobial resistance of Acinetobacter baumannii isolates has been noted during our study.
Literature
1.
go back to reference Biedenbach DJ, Moet GJ, Jones RN: Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY antimicrobial surveillance program (1997–2002). Diagnostic Microbiology and Infectious Disease. 2004, 50: 59-69. 10.1016/j.diagmicrobio.2004.05.003.CrossRefPubMed Biedenbach DJ, Moet GJ, Jones RN: Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY antimicrobial surveillance program (1997–2002). Diagnostic Microbiology and Infectious Disease. 2004, 50: 59-69. 10.1016/j.diagmicrobio.2004.05.003.CrossRefPubMed
2.
go back to reference Sader HS, Jones RN, Andrade-Baiocchi S, Biedenbach DJ, SENTRY Participants Group (Latin America): Four-year evaluation of frequency of occurrence and antimicrobial susceptibility patterns of bacteria from bloodstream infections in Latin America medical centers. Diagn Microbiol Infect Dis. 2002, 44: 271-280. Sader HS, Jones RN, Andrade-Baiocchi S, Biedenbach DJ, SENTRY Participants Group (Latin America): Four-year evaluation of frequency of occurrence and antimicrobial susceptibility patterns of bacteria from bloodstream infections in Latin America medical centers. Diagn Microbiol Infect Dis. 2002, 44: 271-280.
3.
go back to reference Kato-Maeda M, Bautista-Alavez A, Rolon-Montes-de-Oca AL, Ramos-Hinojosa A, Ponce-de-Leon A, Bobadilla-del-Valle M, Ruiz-Palacios G, Sifuentes-Osornio : Increasing trend of antimicrobial drug-resistance in organisms causing bacteremia at a tertiary-care hospital: 1995 to 2000. Rev Invest Clin. 2003, 55: 600-5.PubMed Kato-Maeda M, Bautista-Alavez A, Rolon-Montes-de-Oca AL, Ramos-Hinojosa A, Ponce-de-Leon A, Bobadilla-del-Valle M, Ruiz-Palacios G, Sifuentes-Osornio : Increasing trend of antimicrobial drug-resistance in organisms causing bacteremia at a tertiary-care hospital: 1995 to 2000. Rev Invest Clin. 2003, 55: 600-5.PubMed
4.
go back to reference National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, sixth edition: 2003. Approved standard M7-A6. 2003, NCCLS, Wayne, PA National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, sixth edition: 2003. Approved standard M7-A6. 2003, NCCLS, Wayne, PA
5.
go back to reference National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial susceptibility testing : 2003. Supplemental tables, M100-S13. 2003, NCCLS, Wayne, PA National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial susceptibility testing : 2003. Supplemental tables, M100-S13. 2003, NCCLS, Wayne, PA
6.
go back to reference Arpi M, Victor MA, Moller JK, Jonsson V, Hansen MM, Peterslund NA, Bruun B: Changing etiology of bacteremia in patients with hematological malignancies in Denmark. Scand J Infect Dis. 1994, 26: 157-162.CrossRefPubMed Arpi M, Victor MA, Moller JK, Jonsson V, Hansen MM, Peterslund NA, Bruun B: Changing etiology of bacteremia in patients with hematological malignancies in Denmark. Scand J Infect Dis. 1994, 26: 157-162.CrossRefPubMed
7.
go back to reference Diekema DJ, Pfaller MA, Jones RN, SENTRY Participant Group: Age-related trends in pathogen frequency and antimicrobial susceptibility of bloodstream isolates in North America: SENTRY Antimicrobial Surveillance Program, 1997–2000. Int J Antimicrob Agents. 2002, 20: 412-418. 10.1016/S0924-8579(02)00204-2.CrossRefPubMed Diekema DJ, Pfaller MA, Jones RN, SENTRY Participant Group: Age-related trends in pathogen frequency and antimicrobial susceptibility of bloodstream isolates in North America: SENTRY Antimicrobial Surveillance Program, 1997–2000. Int J Antimicrob Agents. 2002, 20: 412-418. 10.1016/S0924-8579(02)00204-2.CrossRefPubMed
8.
go back to reference Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB: Nosocomial bloodstream infections in US hospitals: analysis of 24179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004, 39: 309-17. 10.1086/421946.CrossRefPubMed Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB: Nosocomial bloodstream infections in US hospitals: analysis of 24179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004, 39: 309-17. 10.1086/421946.CrossRefPubMed
9.
go back to reference Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB: Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clinical Infectious Diseases. 2003, 36: 1103-10. 10.1086/374339.CrossRefPubMed Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB: Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clinical Infectious Diseases. 2003, 36: 1103-10. 10.1086/374339.CrossRefPubMed
10.
go back to reference Tokars JI: Predictive value of blood cultures positive for coagulase-negative staphylococci: implications for patient care and health care quality assurance. Clinical Infectious Diseases. 2004, 39: 333-341. 10.1086/421941.CrossRefPubMed Tokars JI: Predictive value of blood cultures positive for coagulase-negative staphylococci: implications for patient care and health care quality assurance. Clinical Infectious Diseases. 2004, 39: 333-341. 10.1086/421941.CrossRefPubMed
11.
go back to reference Gales AC, Jones RN, Forward KR, Linares J, Sader HS, Verhoef J: Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997–1999). Clin Infect Dis. 2001, 15: S104-13. 10.1086/320183.CrossRef Gales AC, Jones RN, Forward KR, Linares J, Sader HS, Verhoef J: Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997–1999). Clin Infect Dis. 2001, 15: S104-13. 10.1086/320183.CrossRef
12.
13.
go back to reference Goosens H: European status of resistance in nosocomial infections. Chemotherapy. 2005, 51: 177-181. 10.1159/000086919.CrossRef Goosens H: European status of resistance in nosocomial infections. Chemotherapy. 2005, 51: 177-181. 10.1159/000086919.CrossRef
14.
go back to reference Luzzaro F, Vigano EF, Fossati D, Grossi A, Sala A, Sturla C, Saudelli M, Toniolo A, AMCLI Lombardia Hospital Infectious study group: Prevalence and drug susceptibility of pathogens causing bloodstream infections in northern Italy: a two-year study in 16 hospitals. Eur J Clin Microbiol Infect Dis. 2002, 21: 849-55.PubMed Luzzaro F, Vigano EF, Fossati D, Grossi A, Sala A, Sturla C, Saudelli M, Toniolo A, AMCLI Lombardia Hospital Infectious study group: Prevalence and drug susceptibility of pathogens causing bloodstream infections in northern Italy: a two-year study in 16 hospitals. Eur J Clin Microbiol Infect Dis. 2002, 21: 849-55.PubMed
15.
go back to reference Chan CY, Tang JL, Hsueh PR, Yao M, Chen YC, Chen YC, Shen MC, Wang CH, Tsai W, Chang SC, et al: Trends and antimicrobial resistance of pathogens causing bloodstream infections among febrile neutropenic adults with hematological malignancy. J Formos Med Assoc. 2004, 103: 526-532. Chan CY, Tang JL, Hsueh PR, Yao M, Chen YC, Chen YC, Shen MC, Wang CH, Tsai W, Chang SC, et al: Trends and antimicrobial resistance of pathogens causing bloodstream infections among febrile neutropenic adults with hematological malignancy. J Formos Med Assoc. 2004, 103: 526-532.
Metadata
Title
Secular trends of antimicrobial resistance of blood isolates in a newly founded Greek hospital
Authors
Matthew E Falagas
Sofia K Kasiakou
Dimitra Nikita
Panayiota Morfou
George Georgoulias
Petros I Rafailidis
Publication date
01-12-2006
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2006
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-6-99

Other articles of this Issue 1/2006

BMC Infectious Diseases 1/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.